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Abstract: Motile cilia are hairlike organelles that project outward from a tissue-restricted subset of
cells to direct fluid flow. During human development motile cilia guide determination of the left-right
axis in the embryo, and in the fetal and neonatal periods they have essential roles in airway clearance
in the respiratory tract and regulating cerebral spinal fluid flow in the brain. Dysregulation of motile
cilia is best understood through the lens of the genetic disorder primary ciliary dyskinesia (PCD).
PCD encompasses all genetic motile ciliopathies resulting from over 60 known genetic mutations and
has a unique but often underrecognized neonatal presentation. Neonatal respiratory distress is now
known to occur in the majority of patients with PCD, laterality defects are common, and very rarely
brain ventricle enlargement occurs. The developmental function of motile cilia and the effect and
pathophysiology of motile ciliopathies are incompletely understood in humans. In this review, we
will examine the current understanding of the role of motile cilia in human development and clinical
considerations when assessing the newborn for suspected motile ciliopathies.
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1. Introduction
1.1. Primary vs. Motile Ciliopathies and Human Development
Human genetics has revealed cilia as essential directors of human development [1,2].
Cilia, the complex hair-like organelles that extend from the surface of cells, are found
throughout the body. Two classes of cilia, primary and motile, share basic structures but
have distinct components, cellular distribution, and functions that influence development.
Primary (sensory) cilia are well known for their role in cell signaling during development [3,4]. These are present on almost every cell type as sensing and signal transducing
organelles [1,4]. Genetic defects in primary cilia encompass syndromes involving multiple
organ systems, most frequently affecting the structure of the kidney, liver, and pancreas,
but also causing skeletal anomalies, sensory organ deficits, and brain malformations [2].
In contrast, motile cilia are liquid-moving organelles. They contain specialized motor
protein complexes that include members of the dynein family to facilitate bending motions
that move fluids. Motile cilia are limited to a few cell types: nodal cells of the embryonic
node during development, epithelial cells lining the respiratory tract, brain ventricles,
and fallopian ducts, and the sperm flagellum. Despite shared structures and appearance,
developmental syndromes affecting the two cilia types are distinct, as motile ciliopathies
are nearly exclusively the result of genetic variants that hinder their motor proteins [5]. The
function and organization of motile cilia during human development is incompletely understood. Here, we summarize knowledge of motile cilia specifically in human development
and the impact of motile ciliopathies in the newborn.
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1.2. Motile Cilia Structure
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1.3. Appearance of Motile Cilia in the Human Embryo

Motile cilia appear in three structures during development which significantly impact
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unknown function, motile cilia are present in the fetal esophagus at around week 16
of gestation but disappear by birth [23,24]. Multiciliated cells lining the fallopian tubes
in females appear by approximately 14 weeks, but their known function is much later,
establishing the fluid flow that carries oocytes [25–28]. The male sperm flagellum shares
components with motile cilia, but only appear during spermatogenesis after the onset of
puberty [29–31].
2. Motile Cilia Disease in the Human: Primary Ciliary Dyskinesia (PCD)
Failure of motile cilia function is categorized as a single genetic multisystem disorder
called primary ciliary dyskinesia (PCD), which affects approximately 1 in 10,000 births [32,33].
PCD is genetically heterogeneous, with pathologic variants in over 60 different genes coding
for motor protein assembly, structure or regulation causative of disease [33]. Classic features of
PCD as described in children and adults are persistent wet cough, nasal congestion, chronic
sinopulmonary infection, chronic otitis media, organ laterality defects, bronchiectasis, and infertility. Kartagener’s syndrome is a prior-used term for a subgroup of PCD with situs inversus,
sinusitis and bronchiectasis. The neonatal presentation of PCD is tied to pathology from motile
cilia defects during development and at birth. Clinical features include neonatal respiratory
distress in >80% of newborns, laterality defects in approximately 50% (with laterality-based
developmental cardiac defects as a cause of congenital heart disease in a small percent), and in
the exceptionally rare case (<1%) hydrocephalus (Table 1) [33].
Table 1. Developmental roles of motile cilia and clinical impact of ciliopathies in the neonate.
Motile Cilia-Containing Structures
during Development

Developmental Function

Clinical Complication of Motile
Ciliopathies in the Newborn

Embryonic node
Nodal pit cells

Laterality determination
Cardiac formation
Visceral organ position

Situs anomalies
Congenital heart disease

Respiratory tract
Airway epithelial cells

Directed airway fluid movement

Respiratory distress of the newborn
Lung atelectasis

Brain ventricles
Ependymal cells

Directed cerebral spinal fluid movement

Ventricular enlargement
Hydrocephalus

At least 22 of the 60-plus known PCD genes have been specifically reported to cause
neonatal symptoms (Table 2), though it is likely that pathogenic variants in all PCD genes
could impact the neonate. Comprehensive frequencies of most of these variants are unavailable, many are limited to case reports. Motile cilia disorders in PCD are nearly always
the result of autosomal recessive genetic variants, with the exception of a few X-linked
recessive genes (PIH1D3, RPGR, OFD1) and one autosomal dominant gene (FOXJ1) [33].
Pathogenic variants in components of motor protein structure result in absent or ineffective
cilia beating, the most common reported in the neonate are mutations in ODA proteins (e.g.,
DNAH5, DNAH11, DNAI1) or in ‘ruler’ complexes (CCDC39, CCDC40) which determine
placement of IDA and regulatory proteins. Pathogenic variants in genes that are major
controllers of ciliogenesis (MCIDAS, FOXJ1) can result in decreased generation of motile
cilia and a PCD-like phenotype in neonates [34]. Below, we review the developmental
features of motile ciliogenesis in specialized tissues and the relationship to features of
neonates with PCD.
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Table 2. Selected PCD pathogenic variants by class with reported neonatal presentation.

Functional Class
and Gene

Percent of PCD
Caused by the
Pathogenic
Variant

Neonatal
Respiratory
Distress

Laterality Defect

Hydrocephalus

Ref

Outer dynein arm
ARMC4 (ODAD2)
CCDC103
CCDC151
(ODAD3)
DNAH1
DNAH5
DNAH11
DNAI1
TTC25
DNAAF2 (KTU)
DNAAF3
DNAAF4
(DYX1C1)
LRRC6
(DNAAAF11)
SPAG1
ZMYND10

<3%
<4%

Yes
Yes

Yes
Yes

NR
NR

[35,36]
[36,37]

<3%

Yes

Yes

Yes

[38]

<1%
15–29%
6–9%
2–10%
<1%

Yes
Yes
Yes
Yes
Yes

Yes
Yes
Yes
Yes
Yes

NR
NR
NR
NR
NR

[36]
[36,37,39,40]
[37,40,41]
[36,39,42]
[36]

NR
NR

[37,43,44]
[39,40]

<1%
<1%

Dynein axonemal assembly factor
Yes
Yes
Yes
Yes

<1%

Yes

Yes

NR

[39,45]

<1%

Yes

Yes

NR

[37]

<4%
<2–4%

Yes
Yes

Yes
Yes

NR
NR

[37,46]
[47]

CCDC39
CCDC40

4–9%
3–4%

Yes
Yes

Yes
Yes

NR
NR

[36,37,48]
[36,37,48]

HYDIN

<1%

Yes

NR

NR

[36,40,49]

RSPH1
RSPH4A

<1%
<1%

NR
NR

NR
NR

[50,51]
[36]

CCNO
FOXJ1
MCIDAS

<1%
<1%
<1%

NR
Yes
NR

Yes
Yes
Yes

[36,37,52]
[53,54]
[55]

Ruler protein

Central Pair
Radial Spoke
Yes (rare)
Yes
Multiciliogenesis
Yes
Yes
Yes

Abbreviations: Ref, reference.

3. Motile Cilia in the Embryonic Node during Human Embryogenesis
3.1. Development of Embryonic Node Motile Cilia
The mechanism of body asymmetry patterning was elucidated in the 19900 s when cilia
function in the embryonic node was first proven to be required for left-right determination
in mouse models [14,56,57]. The embryonic node, also referred to as the primitive node
or the left-right organizer, is a transient structure that arises from the primitive streak at
gastrulation, likely during the third week of human embryogenesis [17]. Data identifying
the precise timing in human embryos are limited, to our knowledge scanning electron
microscopy of the human node have not been published. Observations from non-human
models have shown that as the streak elongates, a central ‘pit’ of endodermal cells form the
embryonic node [57]. At the midline and extending outward from the pit are 200–300 motile
monociliated nodal cells [58]. Analysis of mouse and zebrafish models show two different
populations of monociliated cells within the node, motile 9 + 0 centrally and sensory
9 + 0 at the lateral edges [59–61]. High-speed video microscopy of the mouse node shows
nodal cilia with clockwise rotational movement at 10 Hz which generates a leftward fluid
flow across the node [15]. This is presumed to be from the predominant population of
9 + 0 motile nodal cilia, with rotational as opposed to bending motion owing to the lack
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of a central pair [14,15,62]. Cilia with varied ultrastructure have also been identified
within the node. Cilia with 9 + 2 and 9 + 4 structures have been found in the zebrafish,
mouse, and rabbit embryonic node but their function and movement pattern are not yet
known; it is presumed they would beat rather than spin (due to the presence of central
microtubules) [63–67]. Motility requires transcription factor FOXJ1, among others, and
functional IDA and ODA motor complexes [68]. The critical period of motile cilia-related
gene expression and nodal flow is transient, over several hours in the mouse, before the
node is absent at the six-somite stage of embryogenesis (approximately 28 days of human
gestation) [69,70]. A cascade of asymmetric gene expression ensues, featuring NODAL,
LEFTY and PITX1 on the left side of the embryo, resulting in activation of tissue-specific
programs for asymmetric organogenesis [71,72].
The cilia-generated leftward laminar flow of extraembryonic fluid within the node
cavity is essential for left-right asymmetry determination. Fluid dynamic models have
shown that the leftward flow pattern is directed by a posterior tilt of the nodal cell and
cilia axis, which is postulated to be driven by WNT5-mediated signaling for planar cell
polarity [73–75]. The mechanism for translation of nodal flow to left-right asymmetry,
extensively studied in genetic mouse and zebrafish models, remains unresolved. Predominant theories are that either the generated fluid flow within the node causes leftward
movement of signaling molecules within the nodal pit to initiate a downstream program
(morphogen gradient model) or that leftward flow generates mechanical stress resulting in
the influx of calcium in an asymmetric cluster of surrounding sensory cilia, triggering the
molecular program (mechanosensory, or ‘two cilia’, model) [60,62,70].
3.2. Left-Right Body Asymmetry
The ultimate development of normal body asymmetry (situs solitus, SS) is identified
by the relative positions of the visceral organs and their blood supply; the heart on the
left side of the chest, lungs with three lobes on the right and two on the left, liver on
right, spleen and stomach on the left, and asymmetric gut rotation. Complete reversal
of this alignment is called situs inversus totalis (SI), which is the most common clinical
presentation of a laterality defect in PCD and may be asymptomatic [60,76]. Intermediate
laterality configurations (situs ambiguous, SA, or heterotaxy) are a diverse spectrum of
anatomic variants above and below the diaphragm, often associated with congenital heart
disease or splenic abnormalities. In some reviews, laterality defects with complex cardiac
malformations differentiate heterotaxy from non-cardiac SA, though there is not a known
unique developmental pathogenesis [77].
3.3. PCD Mutations Associated with Laterality Defects
Pathogenic variants in genes coding for ciliary motor components, including motor assembly proteins and ODA motor proteins, result in node cilia failure and random laterality
generation (SS, SI, or SA) [33,78]. In contrast, genes coding for proteins that are components
of the radial spoke proteins or central pair complex do not have laterality defects. Mutations in several of these central pair and radial spoke ciliary structures have been shown to
result in an abnormal residual twirling motion of cilia in airway multiciliated cells, similar
to the normal motion of the embryonic node 9 + 0 cilia, likely allowing sufficient nodal
function for establishment of normal LR asymmetry [50,79]. Phenotypes of individuals
with mutations in multiciliogenesis genes are divergent based on their function; most,
but not all, classes of mutations affect the function of monociliated nodal cilia, impacting
the determination of laterality. Of the multiciliogenesis genes, CCNO and MCIDAS are
not associated with laterality defects but FOXJ1 is. CCNO is a member of the centriole
amplification pathway, which is not required in the monociliated node cells. Why MCIDAS
variants are not associated with laterality defects is unknown. FOXJ1 variants are associated
with laterality defects including SI owing to the fundamental upstream role of FOXJ1 in
inducing all forms of motile cilia expression, including in the node [53].
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3.4. Clinical Features of Laterality Defects in Neonates with PCD
Laterality defects are manifest by SI in nearly half of neonates with PCD while another
10–12% fall along the spectrum of SA [80]. Population-based studies suggest SI incidence
in all newborns is 1 in 6–8000 (higher than the frequency of PCD) reinforcing that there
are factors downstream of nodal cilia that when altered may cause SI [76,81,82]. Patients
with isolated SI occurring with normal cilia function are generally not clinically affected.
However, heterotaxy (SA) is associated with increased morbidity secondary to complex
congenital heart disease and polysplenia (multiple splenic tissues) or asplenia (lack of
spleen) known to cause immune defects with risk for infection [80,83,84]. The presence
of SI or SA should be considered an early warning bell for clinicians and will typically
trigger a genetic workup to an earlier diagnosis. A recent cohort study of pediatric PCD
patients showed that those with laterality defects were more likely to be diagnosed in
infancy. Overall, 9.4% were diagnosed in the first two months of life and of these 78% had
a laterality defect, while the entire study population had a typical PCD incidence of 48%
laterality defect [85].
3.5. Relationship of Motile Cilia and Laterality Determination with Cardiac Development
Clinically, there has been a long-standing known association between PCD and congenital heart disease (CHD) [80,86]. The genetic relationship was established in murine models
with variants in genes known to cause PCD and immotile nodal cilia [9,87,88]. Populationbased studies of PCD cohorts show increased association with cardiac disease in those
with ODA and IDA gene mutations as opposed to central pair or radial spoke defects [86].
The vast majority of CHD in PCD patients (not including complete dextrocardia) is in the
setting of situs ambiguous, affecting up to 3–6% [78,80,86]. Cardiac defects associated with
heterotaxy include a spectrum from atrial isomerism to complex single ventricle or great
vessel transposition, the latter carrying significantly higher morbidity [77,80,84].
4. Motile Cilia in the Developing Human Respiratory Tract
4.1. Motile Cilia in the Lung Airway Epithelium
Multiciliated cells are present in the upper and lower airway on the epithelium of
the paranasal sinuses, the Eustachian tubes of the ears, the adenoid glands, as well as
throughout the lung’s conducting airway. Airway multiciliated cells contain 200–300 motile
(9 + 2) cilia per cell that beat in synchrony, and, as proven by PCD, are essential for airway
clearance [24,89]. Mucus produced by secretory cells traps particles and bacteria, while
neighboring multiciliated cells facilitate upward fluid propulsion to push debris-laden
mucus out of the airway. Human airway motile cilia are reported to beat at a frequency
of roughly 12 Hz. Beat frequency is reported to be slightly faster in neonates (12–13 Hz)
compared to adults (10–12 Hz), although many factors can affect the ex vivo measurement of
cilia beat frequency measurement including temperature and calcium concentration [90,91].
4.2. Development of the Motile Ciliated Airway Epithelium
Motile cilia arise early in the fetal airway during the pseudoglandular stage of lung
development [19]. Lung development proceeds through five canonical stages based on
anatomic features; embryonic, pseudoglandular, canalicular, saccular, and alveolar, which
have some inherent overlap as the lung develops proximally to distally via branching morphogenesis. The fetal, or embryonic stage comprises early lung organogenesis commenced
by the outpouching of the foregut forming a primitive trachea, followed by lung buds and
bronchi then visceral and parietal pleura, at 4–7 weeks [92,93]. Respiratory epithelium in the
embryonic lung is primarily undifferentiated, expressing transcription factor SOX2 [94–96].
Motile ciliated cell differentiation begins in the pseudoglandular stage (roughly weeks
5–17) and continues through the canalicular (weeks 16–26), and saccular (weeks 24–38)
stages. Molecular markers of ciliogenesis throughout these stages are better described in
mice than in human tissues [97,98]. The airway epithelium is columnar proximally and
lowers in height towards cuboidal-shaped cells distally with growth of new bronchioles
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during the pseudoglandular phase. In this stage, differentiation proceeds proximal to distal,
at which time SOX2+ cells become TP63 basal cells that give rise to secretory and ciliated
cells [94,95]. NOTCH signaling is key in regulation of this differentiation. Activation of
NOTCH leads to the secretory fate, while inhibition of Notch defaults to differentiation of
basal cells into multiciliated cells [99,100].
The future multiciliated airway cell is marked by the presence of a single primary
cilium with a parent (or, ‘mother’) centriole, which are not found on secretory cells [95].
Activation of transcription factors GEMC1, E2F4 and E2F5, halt cell cycle progression
and form a complex with transcriptional cofactor MCIDAS [101,102]. Under the influence
of MCIDAS and cell cycle proteins (e.g., CCNO), centriole numbers are amplified by
two pathways: replication of centrioles from procentrioles and de novo by formation of
structures called deuterosomes [89,103,104]. Deuterosomes release new centrioles that
traffic to the cell surface as basal bodies, providing a template that gives rise to the cilia.
Each basal body has a foot process for anchoring and coordinating unidirectional beating
of the cilia. A newly identified single ‘hybrid’ cilium in each cell, named for its shared
features between primary and motile cilia, is required for basal body alignment and
coordinated cilia beating in the airway [105]. GEMC1 and MCIDAS transcriptional cofactors
induce ciliogenesis by activating transcription factors FOXJ1, FOXN4, and TP73 which
program the production of components required for motile cilia including the motor
protein complexes [104,106,107]. Assembly of the motor protein-containing IDA and ODA
complexes occur within the cell cytoplasm via a poorly understood process. Current
concepts suggest that a set of dynein axonemal assembly factors (DNAAFs) including
DNAAF2, HEATR2, ZMYND10, SPAG1, LRRC6 and others are required for assembly of
the dynein motor containing complexes that form the IDA and ODA. Mutation of any one
of the DNAAFs leads to PCD [18,108].
4.3. Genetic Features of Airway Motile Cilia Defects in Neonates with PCD
As is apparent from molecular roles of regulator proteins described above, impaired
airway epithelial motile ciliary function can result from mutations in genes coding for
proteins along the pathway of motile ciliogenesis (Table 2), leading to impaired airway
clearance. Respiratory distress in the neonate is a recently identified hallmark of PCD,
estimated to occur in 60–85% of patients, but is under appreciated [37,109–111]. Pathogenic
variants in the genes that control key stages of multiciliogenesis, MCIDAS, FOXJ1, CCNO,
and TP73 result in sparse motile cilia and impaired clearance [95]. However, ciliary axoneme generation itself is normal in most of the genetic causes of PCD, indicating that
normal motor function is a predictor of airway clearance. As such, the most common
PCD mutations are also those that result in respiratory symptoms at birth, especially when
pathogenic variants affect motor protein genes coding for the ODA: DNAH5, DNAH11,
and DNAI1 [37]. Additional groups of PCD gene mutations causing respiratory distress are
the dynein assembly proteins (e.g., DNAAF2, DNAAF5) and the ruler proteins (CCDC39,
CCDC40). Mutations in ruler protein genes generally leads to neonatal respiratory distress
and worse respiratory function in childhood and adulthood, compared to isolated ODA
defects [112].
4.4. Clinical Features of Airway Motile Cilia Defects in Neonates with PCD
Impaired mucociliary clearance due to a motile ciliopathy is thought to allow mucus
and particulate matter to obstruct the distal airways at birth during the transition from
liquid to air breathing. The result is decreased lung inflation and atelectasis (collapse),
neonatal respiratory distress, and a predisposition to respiratory infections [37,113–115].
Despite the high frequency of respiratory distress within the PCD population, the likelihood of an individual newborn presenting with respiratory distress secondary to PCD
is low. Term neonatal respiratory failure, irrespective of underlying diagnoses, occurs in
around 2 cases per 1000 live births, typically related to disorders of transition, or infectious
or inflammatory conditions (sepsis, meconium aspiration, birth asphyxia); all disorders
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Figure 2. Neonatal features of primary ciliary dyskinesia.
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the neonate, but an acquired ciliopathy is not well defined. The majority of studies of neonatal airway injury are in animal models with mechanical ventilation, which consistently
show airway inflammation and injury to ciliated cells [121,122]. Limited histologic studies
in premature infants who received mechanical ventilation have shown severe epithelial
denudation with ciliary anomalies accompanied by significantly decreased numbers of
mucous cells, supporting the concept of acquired ciliopathy, as opposed to increased secretion of mucus causing pathology [123]. Some airway pathogens including Pseudomonas
aeruginosa and respiratory syncytial virus have virulence mechanisms that impair cilia
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function, by means of bacterial cell toxins such as pyocyanin or viral suppression of ciliogenesis transcription factor expression [124–126]. PCD-based therapeutic avenues focused
on ciliary augmentation or enhanced mucus clearance strategies would likely translate well
to acquired cilia defects.
5. Motile Cilia in the Developing Human Brain Ventricular System
5.1. Motile Cilia in the Brain Ventricular Epithelium and Cerebral Spinal Fluid Flow
Motile cilia are found in the ependyma and choroid plexus of the brain ventricular
system and the spinal cord central canal, where they may have a faciliatory role in cerebral
spinal fluid (CSF) flow [16,127,128]. CSF is secreted by a specialized subpopulation of
epithelial cells of the choroid plexus and flows through the ventricles to the subarachnoid
space, as a conduit for cell communication and homeostasis [129]. CSF is ultimately
absorbed into the venous system through arachnoid granulations, the projected folds of the
arachnoid matter [129]. Ependymal cell motile cilia beat frequency has not been established
in humans but in mice and rats they roughly double that of respiratory cilia, although with
regional variability [130,131].
5.2. Developmental Control of Motile Ciliogenesis in the Brain Ventricular Ependymal Cells
The ventricular system emerges soon after completion of neural tube closure at human
embryonic day 30, as cells induce radial glial cell progenitors under control of FOXG1,
LHX2, PAX6, and EMX2, as shown in mouse models [132,133]. Further differentiation
starts around week 7 of human development in a caudal-to-rostral direction in the brain
and rostral-to-caudal in the spinal cord [134]. Radial glial cells are the stem cells that give
rise to the multiciliated choroid and ependymal cells well after the ventricles are formed,
at around 25 weeks’ gestation [133,134]. Ependymal cells ciliate soon after, but cilia are
immature in orientation and short in length until near term [127,134,135]. Detailed analysis
of cilia throughout the ventricular system of the mouse brain has identified at least three
types of ciliated cells that control CSF flow on the ependymal wall: those with abundant
cilia ranging 20–100 per cell, some with one or two motile cilia found in the third and
fourth ventricle, and the non-motile monociliated cells in the third ventricle [136–138]. The
regulation of differentiation of ciliated ependymal cells in the human is presumed to be
similar to animal models; dependent on NOTCH signaling with GEMC1 and MCIDAS
as upstream regulators coupled with downstream FOXJ1 expression for generation of
motile cilia [24,139–141]. As in the respiratory tract, planar cell polarity protein Vangl2 is
implicated for ciliary beat alignment [142,143].
5.3. Clinical Features of Brain Ependymal Motile Cilia Dysfunction in Neonates with PCD
Nearly all genetic mouse models of PCD develop hydrocephalus, consistent with the
function of motile cilia to move fluids (CSF), but in humans with PCD hydrocephalus is
exceedingly rare at less than 1% of the overall PCD population [9,16,144–146]. Multiple
theories have been advanced to explain the relative rarity in PCD patients. First, the ventricles are anatomically different in rodents and humans. Humans have a larger ventricular
system with relatively wider connecting passages, less prone to obstruction [16]. Second,
ependymal cells may have additional roles in the mouse compared to the human brain,
including facilitating production of CSF. Third, the glycoprotein composition of CSF is
different between species, perhaps affecting flow [144]. Additionally, there are differences
in brain development, notably the timing of forebrain neurogenesis [140].
In all human infants, hydrocephalus has an incidence of 0.5–1 cases per 1000 births,
and is associated with developmental delay, cerebral palsy, and seizure disorders [147].
Untreated hydrocephalus carries a mortality rate of 50% [147,148]. While it may arise
from any defect related to CSF production and flow, the most common etiologies include
congenital infection of the newborn, developmental anomalies obstructing CSF flow (e.g.,
aqueductal stenosis), or intraventricular hemorrhage [149].
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When reported, hydrocephalus in PCD patients is most closely associated with variants
in genes resulting in reduced generation of motile cilia (FOXJ1, MCIDAS, TP73, CCNO).
In patients with these pathogenic variants the prevalence of hydrocephalus approaches
10% [150,151]. Variants in FOXJ1 are most consistently associated with hydrocephalus,
with one case series present in all of 11 subjects [53]. In mouse models, FOXJ1 has a key role
in neurogenesis and ependymal cell maturation, the alteration of which may contribute to
hydrocephalus [141]. Other reported cortical malformations are lissencephaly in patients
with TP73 mutations and abnormal respiratory cilia function [151]. Mild ventricular dilation
and severe prenatal hydrocephalus has been identified only sporadically in case reports
of PCD families with gene mutations affecting structural defects in central microtubules
and dynein arms [145,152]. Comprehensive evaluation of ventricular size has not been
performed in cohorts of patients with PCD. It is possible that subclinical flow-related
changes are more often present or that mild ventriculomegaly occurs short of macrocephaly,
with undetermined consequence. A small cohort study of PCD children revealed increased
behavioral and developmental delay compared to control groups [153]. It is possible that
subtle neurologic changes as the result of altered brain motile cilia contribute to these
developmental differences.
6. Evaluation and Management of the Newborn with Suspected PCD
6.1. Identification of the Newborn with Suspected PCD
Overall, PCD is considered to be under-recognized, with estimates suggesting that as
few as 10% of all individuals with PCD have been definitively diagnosed and appropriately
managed in specialized PCD centers [154]. Diagnosis of PCD in the newborn period is
particularly challenging and requires a high index of suspicion. In a recent retrospective
cohort study of pediatric patients with PCD only 9% were diagnosed in infancy (in this
cohort, 55% had neonatal respiratory distress and 42% laterality defects, with co-occurrence
in 29%) [85]. PCD diagnostic guidelines by the European Respiratory Society (ERS) and the
American Thoracic Society (ATS) are both derived from data in children with the mean ages
of 7–9 years and predicated on historical features [110,155]. The ATS diagnostic algorithm
for PCD requires two of four key clinical features: unexplained neonatal respiratory distress
in a term infant, year-round daily cough beginning before 6 months of age, year-round
daily nasal congestion beginning before 6 months of age, and organ laterality defect.
By definition, two of these criteria require progression past infancy. Similarly, the ERS
algorithm commences by asking if a daily wet cough is present from early childhood, not
applicable to the neonatal population.
Diagnosis in the neonatal period requires recognition of the clinical phenotype (Figure 2).
Evolving experience and data suggest that evaluation for PCD in the neonatal period is based
on a phenotype that varies from the classical features identified an older child. Instead, the
diagnosis is centered on respiratory distress, and co-occurring laterality defects or a family
history of PCD (Table 3).
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Table 3. Indications for diagnostic testing of primary ciliary dyskinesia (PCD) in the newborn.
Criteria for Neonatal Evaluation of PCD
1.

Term newborn with >48 h unexplained lung atelectasis (particularly with lobar collapse) or
neonatal respiratory distress 1

AND
2.
OR

A laterality defect

3.

Family history of PCD

Diagnostic Testing for PCD in the Neonatal Period
1.
2.
3.

Genetic diagnosis with pathogenic variants in a known PCD causative gene
Structural ciliary defect visualized on transmission electron microscopy 2
Ciliary functional abnormalities seen on repeated measures with high-speed video
microscopy (beat frequency and/or waveform) 2

1

Term defined as greater or equal to 37 weeks’ gestation. Neonatal respiratory distress defined by the need for
supplemental oxygen or positive pressure ventilation for >48 h without alternative explanation. 2 Transmission
electron microscopy (TEM) to evaluate cilia ultrastructure and high-speed video microscopy (HSVM) to evaluate
cilia beat frequency and wave form, only available at specialized PCD centers.

6.2. Diagnostic Testing of the Neonate with Suspected PCD
Assessment of the neonate is centered in imaging and genetic testing (Table 4). Chest
X-ray will evaluate for atelectasis and screen for laterality defects [37,120]. Chest CT and
surgical lung biopsy are not indicated in the neonate to evaluate for PCD but are part of
diagnostic algorithms for interstitial lung diseases that cause respiratory distress in the
term newborn and should be considered only in consultation with subspecialists [156].
Echocardiography should be performed to evaluate for congenital heart disease and related
laterality defects of the vessels. To assess for visceral organ laterality defects, abdominal
ultrasound with attention to polysplenia or asplenia is necessary. Simple measurement
of the occipital frontal head circumference standardized appropriately against gestational
age-adjusted growth curves will assess for macrocephaly and screen for hydrocephalus.
As ventricular dilatation is likely under-recognized in PCD, screening head ultrasound is
a reasonable consideration. Genetic testing using commercially available PCD panels is
the most straightforward confirmatory approach in the newborn. Standard panels now
include over 32 genes, and these extended spectrum panels have excellent specificity and
sensitivity generally around 70% depending on the panel [8,120,157]. Testing should be
done in conjunction with genetic or PCD specialists to assess specific allelic mutations and
appropriately interpret variants of unknown significance.
Table 4. Initial diagnostic evaluation of the newborn with suspected primary ciliary dyskinesia.
System

Workup

Respiratory

Chest X-ray

Cardiac

Echocardiogram

Gastrointestinal

Abdominal ultrasound
(with attention to visceral organ laterality,
splenic abnormalities)

Neurologic

Occipital frontal head circumference (OFC)
Head ultrasound

Genetic

Genetic testing for cystic fibrosis,
immunodeficiency, surfactant deficiency
Comprehensive PCD genetic panel

Nasal nitric oxide (nNO) testing is a useful screening test in older children and adults
with suspected PCD [158,159]. Testing is not validated in children <5 years of age or

Cells 2022, 11, 125

12 of 20

recommended in the neonate [110,120]. Pilot studies of nNO measurement in newborns
have shown feasibility, though values are significantly lower when compared to control
or disease reference ranges. Low levels are attributed to physiologic differences in nNO
production in the underdeveloped sinuses of the infant [160]. Evaluation of cilia ultrastructure by transmission electron microscopy (TEM), or cilia movement by high-speed video
light-microscopy (HSVM) are technically difficult and should be limited to specialized
PCD centers [110,120]. Obtaining airway cells in the neonate poses technical challenges.
Brush biopsies of the nares or upper respiratory tract require significant expertise to isolate
multiciliated cells for TEM, HSVM, or culture.
6.3. Management of the Newborn with Suspected or Confirmed PCD
There are no specific treatments for PCD. Instead, PCD is managed with symptomdirected care based in expert opinion and extrapolation from other disease processes that
have obstructive physiology such as cystic fibrosis [120,161]. Likewise, treatments for
adults and children are extrapolated to address problems in the newborn.
In the neonatal period, management of respiratory distress often requires positive
pressure ventilation with or without supplemental oxygen [37]. Airway clearance is the
cornerstone of PCD treatment but is more difficult in the newborn who cannot actively
participate in clearance maneuvers. Daily inhaled normal saline and chest physiotherapy
with gentle manual percussion are recommended [120]. Data on drug therapy for PCD
remain nearly all anecdotal. Mucolytics (such as n-acetylcysteine or dornase alpha) coopted from their use in CF patients have not been shown to be beneficial and are not
recommended [120]. Case reports have suggested regular use of nebulized dornase alpha
improve PCD patient pulmonary function testing and pulmonary symptoms, however
benefits are unlikely in the neonate where high neutrophil burdens (associated with high
airway DNA levels) are not established by chronic infection [162]. Likewise, inhaled
corticosteroids are not advised in the neonatal period due to insufficient evidence of benefit
and some evidence for increased associated mortality with use [163–165]. Beta-adrenergic
agonists, sometimes used as bronchodilators in PCD, increase cilia beat frequency and
theoretically may have a role in improving residual cilia function, though no current data
support use for this purpose [164,166]. Modulating calcium-dependent cilia activity using
phosphodiesterase inhibitors to increase cilia beating remains theoretical [167].
Specialty referral is often a component of care for infants with PCD. For those neonates
with co-occurring laterality defects, particularly with congenital heart disease and heterotaxy syndromes, consultation with a cardiologist is paramount. Isolated laterality defects,
not involving the heart or splenic functional anomalies, do not require further management,
as they have been not been found to be associated with negative outcomes. In the case of
splenic abnormalities referral should be made to an immunologist as functional deficits
frequently accompany this disorder [83]. The rare occurrence of ventricular enlargement or
hydrocephalus requires neurologic subspecialty care [168]. Genetic counseling should be
offered if the diagnosis of PCD is confirmed.
Neonates with PCD should be considered candidates for RSV immune prophylaxis
during the first two years of life [120,169]. Prophylaxis with antibiotics is not recommended,
although a large multicenter randomized trial in preventive daily azithromycin use in PCD
patients ages 7–50 reduced respiratory exacerbations, infants were not studied [170]. PCD
patients are at high risk of hearing loss, which is reported in up to half of all PCD patients. Screening hearing exams should be obtained in all neonates at the time of diagnosis,
and routine audiology follow-up continued under the guidance of otolaryngology consultants [171].
PCD management in the neonatal period is only the beginning of a life-long journey
for patients. Care should be directed by PCD centers with routine follow-up, including
management of potential infertility. Studies on the impact of disease on quality of life
unfortunately show significant burden to affected individuals, which may be partially
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mitigated by early care [172]. Therapies to restore cilia function are under investigation
with potential for success [161].
7. Conclusions and Gaps in Knowledge
Motile ciliopathies have significant impact on the newborn, which are understood
through the biology of human development. Much of what is currently known of human
motile cilia development is deduced from non-mammalian vertebrate models. There
remain many gaps in our understanding:
1.

2.

3.

4.

Embryonic nodal signaling is postulated but not fully defined, in particular how
signaling and dysfunction in the node translates to specific cardiac laterality defects
is unknown.
In the respiratory system, it is clear that cilia are required for airway clearance, but
the role of cilia in the liquid-filled lung, the effect of cilia-mediated flow on the
developing lung, and exactly how motile ciliopathies cause respiratory distress at
birth is not known.
The role of ventricular motile cilia in the development of neural function, outside
of the rare contribution by hydrocephalus, is unknown. Perturbations in CSF flow
related to malfunctioning cilia may be insufficient to cause clinically apparent disease
but may have consequences yet unknown in the developing brain.
All motile ciliopathies are studied through the genetic disease PCD and its models,
while very little is known of acquired cilia disease in neonates. The respiratory
tract and brain ventricular system continue to play critical roles after development
throughout adult life and an acquired ciliopathy may develop without underlying
genetic disease.

Continued study of human development and disease in the neonate can provide
insight into the biology of motile cilia and improve our management of the newborn with
motile ciliopathy.
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